Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Liquid Genomics

Liquid Genomics
2013 FOUNDED
M&A STATUS
1-10 EMPLOYEES
M&A LATEST DEAL TYPE
$7.24M LATEST DEAL AMOUNT
Description

Provider of blood-based biomarker intended to be used for tumor profiling. The company's blood-based biomarker utilizes non-invasive blood-based molecular testing methods enabling cancer patients to assess gene mutations, expressions, and fusions to inform treatment strategies for chemotherapy.

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Acquirer
Primary Office
  • 9920 Jefferson Boulevard
  • Culver City, CA 90501
  • United States

+1 (310) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Liquid Genomics’s full profile, request a free trial.

Liquid Genomics Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Merger/Acquisition 31-Mar-2017 $7.24M 00.000 00.000 Completed Generating Revenue
2. Early Stage VC (Series A) 18-Jan-2017 00.000 00.000 00.000 Completed Generating Revenue
1. Early Stage VC (Series A) 28-Mar-2016 $3.24M $3.24M 00.000 Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Liquid Genomics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate ($) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned
Series A 00,000,000 00.000000 00.00 00.00 00.00 00 00.00 00.000
To view this company’s complete Cap Table, request access »

Liquid Genomics Executive Team (2)

Name Title Board
Seat
Contact
Info
Kathleen Danenberg Co-Founder, Board Member, President & Chief Executive Officer

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »